6,862
Views
119
CrossRef citations to date
0
Altmetric
Review Article

Identifying an indoor air exposure limit for formaldehyde considering both irritation and cancer hazards

Pages 672-721 | Received 25 Aug 2010, Accepted 16 Mar 2011, Published online: 02 Jun 2011

References

  • Abraham M.H. (2001). The correlation and prediction of VOC thresholds for nasal pungency, eye irritation and odour in humans. Indoor Built Environ. 10:3–7.
  • Agency for Toxic Substances and Disease Registry (ATSDR). (1999). Toxicological Profile for Formaldehyde. Washington, DC: US Department of Health and Human Services, Public Health Service.
  • Agency for Toxic Substances and Disease Registry (ATSDR). (2007a). Revised Health Consultation; Formaldehyde Sampling at FEMA Temporary Housing Units, Baton Rouge, Louisiana, February 2007. http://www.atsdr.cdc.gov/substances/formaldehyde/pdfs/revised_formaldehyde_report_1007.pdf.
  • Agency for Toxic Substances and Disease Registry (ATSDR). (2007b). Health Consultation; Formaldehyde Sampling at FEMA Temporary Housing Units, Baton Rouge, Louisiana, October 2007. http://www.atsdr.cdc.gov/HAC/PHA/fema_housing_formaldehyde/formaldehyde_report_0507.pdf.
  • Agency for Toxic Substances and Disease Registry (ATSDR). (2008). Medical Management Guidelines for Formaldehyde (HCHO). Available at: http://www.atsdr.cdc.gov/mhmi/mmg111.html. Sept. 30, 2010.
  • Alarie, Y., Luo, J.L. (1986). Sensory irritation by airborne chemicals: A basis to establish acceptable levels of exposure. In: Barrow, C.S., (ed.) Toxicology of the Nasal Passages. Washington, DC: Chemical Industry Institute of Toxicology., McGraw Hill Publishing, pp. 91–100.
  • Alarie, Y.C., Anderson, R.C. (1979). Toxicologic and acute lethal hazard evaluation of thermal decomposition products of synthetic and natural polymers. Toxicol. Appl. Pharmacol. 51(2):341–362.
  • Alexandersson, R., Hedenstierna, G. (1989). Pulmonary function in wood workers exposed to formaldehyde: A prospective study. Arch. Environ. Health 44:5–11.
  • American Conference of Governmental Industrial Hygienists (ACGIH). (1992). Formaldehyde. Documentation of the Threshold Limit Values for Chemical Substances.Cincinnati, Ohio..
  • Andersen I, Molhave L. (1983). Controlled human studies with formaldehyde. In: Gibson JE, ed. Formaldehyde Toxicity. Washington DC: Hemisphere Publishing Corporation, 154–165.
  • Andersen, M.E., Clewell, H.J., Bermudez, E., Wilson, G.A., Thomas, R.S. (2008). Genomic signatures and dose dependent transitions in nasal epithelial responses to inhaled formaldehyde in the rat. Toxicol. Sci. 105:368–383.
  • Andersen, M.E., Clewell, H.J. 3rd, Bermudez, E., Dodd, D.E., Willson, G.A., Campbell, J.L., Thomas, R.S. (2010). Formaldehyde: Integrating dosimetry, cytotoxicity and genomics to understand dose-dependent transitions for an endogenous compound. Toxicol. Sci. 118(2):716–31.
  • Anderson, R.C., Stock, M.F., Sawin, R., Alarie, Y. (1979). Toxicity of thermal decomposition products of urea formaldehyde and phenol formaldehyde foams. Toxicol. Appl. Pharmacol. 51:9–17.
  • Appelman, L.M., Woutersen, R.A., Zwart, A. (1988). One-year inhalation toxicity study of formaldehyde in male rats with a damaged or undamaged nasal mucosa. J. Appl. Toxicol. 8:85–90.
  • Arts, J.H., de Heer, C., Woutersen, R.A. (2006a). Local effects in the respiratory tract: Relevance of subjectively measured irritation for setting occupational exposure limits. Int. Arch. Occup. Environ. Health. 79:283–298.
  • Arts, J.H., Rennen, M.A., and de Heer, C. (2006b). Inhaled formaldehyde: Evaluation of sensory irritation in relation to carcinogenicity. Regul Toxicol Pharmacol. 44:144–160.
  • Baan, R., Grosse, Y., Straif, K., Secretan, B., El Ghissassi, F., Bouvard, V., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., Cogliano, V. (2009). A review of human carcinogens–—Part F: Chemical agents and related occupations. Lancet Oncol 10:1143–1144.
  • Bachand, A., Mundt, K.A., Mundt, D.J., Montgomery, R.R.. (2010). Epidemiological studies of formaldehyde exposure and risk of leukemia and nasopharyngeal cancer: A meta-analysis. Crit. Rev. Toxicol. 40:85–100.
  • Ballarin, C., Sarto, F., and Giacomelli, L. (1992). Micronucleated cells in nasal mucosa of formaldehyde exposed workers. Mutat. Res. 280:1–7.
  • Barrow, C.S., Buckley, L.A., James, R.A., Steinhagen, W.H., Chang, J.C.F. (1986). Sensory irritation: Studies on correlation to pathology, structure-activity, tolerance development, and prediction of species differences to nasal injury. In: Barrow, C.S., (ed.) Toxicology of the Nasal Passages. Washington, DC: Chemical Industry Institute of Toxicology., Mc-Graw Hill Publishing, 91–100.
  • Battelle Labs. (1981). Final Report on a Chronic Inhalation Toxicology Study in rats and Mice Exposed to Formaldehyde to the Chemical Industry Institute of Toxicology. Columbus, OH: Battelle Columbus Laboratories.
  • Beane Freeman,L.E., Blair, A., Lubin, J.H., Stewart, P.A., Hayes, R.B., Hoover, R.N., Hauptmann, M. (2009). Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries: The National Cancer Institute Cohort. J. Natl. Cancer Inst. 101:751–61.
  • Bender, J. (2002). The use of noncancer endpoints as a basis for establishing a reference concentration for formaldehyde. Regul Toxicol Pharmacol. 35:23–31.
  • Bender, J.R., Mullin, L.S., Graepel, G.J., Wilson, W.E. (1983). Eye irritation response of humans to formaldehyde. Am Indust Hyg Assoc J. 44:463–465.
  • Bracken, M.J., Leasa, D.J., Morgan, W.K. (1985). Exposure to formaldehyde: Relationship to respiratory symptoms and function. Can J Public Health 76:312–316.
  • BfR. (2006). Toxicological Assessment of Formaldehyde. xx: Federal Institute for Risk Assessment., Opinion of BfR No. 023/2006 of 30 March 2006. Berlin.
  • Boffetta P, McLaughlin JK, La Vecchia C, Tarone RE, Lipworth L, Blot WJ. (2008). False-positive results in cancer epidemiology: A plea for epistemological modesty. J Natl Cancer Inst 100:988–995.
  • Boobis AR, Cohen SM, Dellarco V, McGregor D, Meek ME, Vickers C, Willcocks D, Farland W. (2006). IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit Rev Toxicol 36:781–792.
  • Bosetti C, McLaughlin JK, Tarone RE, Pira E, La Vecchia C. (2006). Formaldehyde and cancer risk: A quantitative review of cohort studies through 2006. Ann Oncol 19:29–43.
  • Boysen M, Zadig E, Digernes V. (1990). Nasal mucosa in workers exposed to formaldehyde: A pilot study. Br J Ind Med 47:116–121.
  • Burkhart KK, Kulig KW, McMartin K.E. (1990). Formate levels following a formalin ingestion. Vet Hum Toxicol 32:135–137.
  • Cal/EPA. (2005). Letter from J. R. Froines, Chair of Scientific Review Panel, to B. Jordan, Interim Chairperson, Air Resources Board, California Environment Protection Agency.
  • Casanova M, Heck Hd’A Everitt, JI. (1988). Formaldehyde concentrations in the blood of Rhesus monkeys after inhalation exposure. Food Chem Toxicol 26:715–716.
  • Cabanes PA, Lambrozo J, Aubier M. (2007). Effect of formaldehyde on asthmatic response to inhaled allergen challenge. Environ Health Perspect 115:210–214.
  • Caldwell DJ. (1999). Review of mononuclear cell leukemia in F-344 rat bioassays and its significance to human cancer risk: A case study using alkyl phthalates. Regul Toxicol Pharmacol 30:45–53.
  • Centers for Disease Contol and Prevention (CDC). (2009). Final Report on Formaldehyde Levels in FEMA-Supplied Travel Trailers, Park Models, and Mobile Homes (July 2, 2008). Atlanta: CDC. http://www.cdc.gov/nceh/ehhe/trailerstudy/
  • Cohen SM, Klaunig J, Meek ME, Hill RN, Pastoor T, Lehman-McKeeman L, Bucher J, Longfellow DG, Seed J, DellarcoV, Fenner-Crisp P, Patton D. (2004). Evaluating the human relevance of chemically induced animal tumors. Toxicol Sci 78:181–186.
  • Coggon D, Harris EC, Poole J, Palmer KT. (2003). Extended follow-up of a cohort of British chemical workers exposed to formaldehyde. J Natl Cancer Inst 95:1608–1615.
  • Cohen SM, Meek ME, Klaunig JE, Patton DE, Fenner-Crisp PA. (2003). The human relevance of information on carcinogenic modes of action: Overview. Crit Rev Toxicol 33:581–589.
  • Collins JJ, Lineker GA. (2004). A review and meta-analysis of formaldehyde exposure and leukemia. Regul Toxicol Pharmacol 40:81–91.
  • Concise International Chemical Assessment Document (CICAD). (2002). Formaldehyde #40. Geneva: World Health Organization.
  • Conolly RB, Kimbell JS, Janszen D, Schlosser PM, Kalisak D, Preston J, Miller FJ. (2004). Human respiratory tract cancer risks of inhaled formaldehyde: Dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset. Toxicol Sci 82:279–296.
  • Crump KS, Chen C, Fox JF, Van Landingham C, Subramaniam R. (2008). Sensitivity analysis of biologically motivated model for formaldehyde-induced respiratory cancer in humans. Ann Occup Hyg 52:481–495.
  • Crump KS, Chiu WA, Subramaniam RP. (2010). Issues in using human variability distributions to estimate low-dose risk. Environ Health Perspect 118:387–393.
  • Dalton P. (2002). Odor, irritation and perception of health risk. Int Arch Occup Environ Health 75:283–290.
  • Dalton P. (2003). Upper airway irritation, odor perception and health risk due to airborne chemicals. Toxicol Lett 140–141:239–248.
  • Day JH, Lees REM, Clark RH. (1984). Respiratory response to formaldehyde and off-gas of urea formaldehyde foam insulation. Can Med Assoc J 131:1061–1065.
  • Deitrich RA, Petersen D, Vasiliou V. (2007). Removal of acetaldehyde from the body. In: Chadwick DJ, Goode J, eds. Acetaldehyde-Related Pathology: Bridging the Disciplinary Divide. Novartis Foundation Symposium 285. Chichester: Wiley, 23–51.
  • Dellarco VG, Baetcke K. (2005). A risk assessment perspective: Application of mode of action and human relevance frameworks to the analysis of rodent tumor data. Toxicol Sci 86:1–3.
  • DeVoney D, Jinot J, Keshava C, Hsu C, Whalan J, Vandenberg J. (2006a). A hypothesized mode of action in support of the biological plausibility of formaldehyde-induced lymphohematopoietic malignancies. Poster presentation; Society for Risk Analysis, December 3-6, 2006–Baltimore, MD.
  • DeVoney D, Vandenbereg J, Whalen J. (2006b). Hypothesized mode of action for formaldehyde-induced lymphoid malignancies. Poster presentation; Society of Toxicology Annual Meeting, March 5-9, 2006, San Diego, CA.
  • Dhareshwar SS, Stella VJ. (2008). Your prodrug releases formaldehyde: Should you be concerned? No! J Pharm Sci 97:4184–4193.
  • DHHS/CDC/DHS/FEMA/EPA. (2008). Formaldehyde Exposure in Homes: A Reference for State Officials to Use in Decision-making. http://www.cdc.gov/nceh/ehhe/trailerstudy/pdfs/08_118152_Compendium%20for%20States.pdf.
  • Doty RL, Cometto-Muňiz JE, Jalowayski AA, Dalton P, Kendal-Reed M, Hodgson M. (2004). Assessment of upper respiratory tract and ocular irritative effects of volatile chemicals in humans. Crit Rev Toxicol 34:85–142.
  • Duhayon S, Hoet P, Van Maele-Fabry G, Lison D. (2008). Carcinogenic potential of formaldehyde in occupational settings: A critical assessment and possible impact on occupational exposure levels. Int Arch Occup Environ Health 81:695–710.
  • Eastmond D. (1998). Chemical and Radiation Leukemogenesis in Humans and Rodents and the Value of Rodent Models for Assessing Risks of Lymphohematopoietic Cancers. Washington, DC: National Center for Environmental Assessment (NCEA). EPA/600/R-97/090.
  • Edling C, Hellquist H, Odkvist L. (1988). Occupational exposure to formaldehyde and histopathological changes in the nasal mucosa. Br J Ind Med 45:761–765.
  • Eells JT, McMartin KE, Black K. (1981). Formaldehyde poisoning: Rapid metabolism to formic acid. J Am Med Assoc 246:1237–1238.
  • Environment Canada and Health Canada. (2002). Existing Substances Evaluation, Assessment Report—Formaldehyde. Available at: http://www.ec.gc.ca/substances/ese/eng/psap/final/formaldehyde.cfm.
  • Ezratty V, Bonay M, Neukirch C, Orset-Guillossou G, Dehoux M, Koscielny S, Cabanes PA, Lambrozo J, Aubier M. (2007). Effect of formaldehyde on asthmatic response to inhaled allergen challenge. Environ Health Perspect 115:210–214.
  • Fox CH, Johnson FB, Whiting J, Roller RP. (1985). Formaldehyde fixation. J Histochem Cytochem 33:845–853.
  • Freestone J, Bentley A. (1989). Case of formaldehyde poisoning. Br J Pharm Pract 11:20–21.
  • Gaffney SH, Paustenbach DJ. (2007). A proposed approach for setting occupational exposure limits for sensory irritants based on chemosensory models. Ann Occup Hyg 51:345–356.
  • Garcia GJ, Schroeter JD, Segal RA, Stanek J, Foureman GL, Kimbell JS. (2009). Dosimetry of nasal uptake of water-soluble and reactive gases: A first study of interhuman variability. Inhal Toxicol 21:607–618.
  • Garrett MH, Hooper MA, Hooper BM, Rayment PR, Abramson MJ. (1999). Increased risk of allergy in children due to formaldehyde exposure in homes. Allergy 34:330–337.
  • Garrett MH, Rayment PR, Hooper MA, Hooper MJ, Rayment PR, Hooper BM. (1998). Indoor airborne fungal spores house dampness and associations with environmental factors and respiratory health in children. Clin Exp Allergy 28:459–467.
  • Garry VF, Oatman L, Pleus R. (1980). Formaldehyde in the home: Some environmental disease perspectives. Minn Med 63:107–111.
  • Golden R, Pyatt D, Shields P. (2006). Formaldehyde as a potential human leukemogen: An assessment of biological plausibility. Crit Rev Toxicol 36:135–153.
  • Goldstein B.D., Smith M.T. (2010). Formaldehyde. Identification of research needs to resolve the carcinogenecity of high priority IARC carcinogens. IARC Technical Publication NO. 42. Lyon: IARC. AND IARC (International Agency for Research and Cancer). (2009) IARC Monographs on the Evaluation of Carcinogenic 18 Risks to Humans. Vol 100. A review of human carcinogens- Part F: Chemical agents and related occupations. 19 Lyon, France: International Agency for Research on Cancer.
  • Gorski P, Tarkowski M, Krakowiak A. (1992). Neutrophil chemiluminescence following exposure to formaldehyde in healthy subjects and in patients with contact dermatitis. Allergol Immunopathol (Madr) 20:20–23.
  • Grammer LC, Harris KE, Cugell DW, Patterson R. (1993). Evaluation of a worker with possible formaldehyde-induced asthma. J Allergy Clin Immunol 92(1 Pt 1):29–33.
  • Green DJ, Sauder LR, Kulle TJ, Bascom R. (1987). Acute response to 3.0 ppm formaldehyde in exercising healthy nonsmokers and asthmatics. Am Rev Respir Dis 135:1261–1266.
  • Harrington JM, Shannon HS. (1975). Mortality study of pathologists and medical laboratory technicians. Br Med J 4:329–332.
  • Hauptmann M, Lubin JH, Stewart PA, Hayes RB, Blair A. (2003). Mortality from lymphohematopoietic malignancies among workers in formaldehyde industries. J Natl Cancer Inst 95:1615–1623.
  • Hauptmann M, Lubin JH, Stewart PA, Hayes RB, Blair A. (2004). Mortality from solid cancers among workers in formaldehyde industries. Am J Epidemiol 159:1117–1130.
  • Hauptmann M, Stewart PA, Lubin JH, Beane Freeman LE, Hornung RW, Herrick RF, Hoover RN, Fraumeni JF Jr, Blair A, Hayes RB. (2009). Mortality from lymphohematopoietic malignancies and brain cancer among embalmers exposed to formaldehyde. J Natl Cancer Inst 16;101(24):1696–1708.
  • Hayes RB, Blair A, Stewart PA. (1990). Mortality of U.S. embalmers and funeral directors. Am J Ind Med 18:641–652.
  • Health Canada. (2005). Proposed Residential Indoor Air Quality Guidelines for Formaldehyde. http://www.hc-sc.gc.ca/ewh-semt/alt_formats/hecsesc/pdf/pubs/air/formaldehyde/informaldehyde-eng.pdf.
  • Heck H, Casanova-Schmitz M, Dodd P, Schachter E, Witek T, Tosun T. (1985). Formaldehyde (CH2O) concentrations in the blood of humans and Fischer 344 rats exposed to CH2O under controlled conditions. Am Ind Hyg Assoc J 46:1–3.
  • Heck H, Casanova M. (2004). The implausibility of leukemia induction by formaldehyde: A critical review of the biological evidence for distant-site toxicity. Regul Toxicol Pharmacol 40:92–106.
  • Hellman TM, Small FH. (1974). Characterization of the odor properties of 101 petrochemicals using sensory method. J Air Pollut Control Assoc 24:979–982.
  • Hester S.D., Barry W.T., Zou F., Wolf D.C. (2005). Transcriptomic analysis of F344 rat nasal epithelium suggests that the lack of carcinogenic response to glutaraldehyde is due to its greater toxicity compared to formaldehyde. Toxicol Pathol. 33(4):415–24.
  • Hester S.D., Benavides G.B., Yoon L., Morgan K.T., Zou F., Barry W., Wolf D.C. (2003). Formaldehyde-induced gene expression in F344 rat nasal respiratory epithelium. Toxicology. 187(1):13–24.
  • Holmstrom M, Wilhelmsson B, Hellquist H. (1989). Histological changes in the nasal mucosa in persons occupationally exposed to formaldehyde alone and in combination with wood dust. Acta Otolaryngol (Stockh) 107:120–129.
  • Holness DL, Nethercott J.R. (1989). Health status of funeral service workers exposed to formaldehyde. Arch Environ Health 44:222–228.
  • Horvath EP, Anderson H, Pierce WE. (1988). Effects of formaldehyde on the mucous membranes and lungs: A study of an industrial population. J Am Med Assoc 259:701–707.
  • Imbus HR. (1985). Clinical evaluation of patients with complaints related to formaldehyde exposure. J Allergy Clin Immunol 76:831–840.
  • INDEX Project. (2005). Formaldehyde. Final Report. Critical Appraisal of the Setting and Implementation of Indoor Exposure Limits in the EU. Ispra, Italy: European Commission, Joint Research Centre, Institute for Health and Consumer Protection, Physical and Chemical Exposure Unit (JRC/IHCP/PCE).
  • International Agency for Research on Cancer (IARC). (2006). Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxypropan-2-ol. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon: WHO, IARC.
  • International Agency for Research on Cancer (IARC). (2009). Formaldehyde. Mechanistic and other Relevant Data. Chap. 4. Vol. 100F. Monograph No. 09. Lyon: WHO, IARC.
  • International Life Sciences Institute (ILSI). (1992). Similarities and Differences between Children and Adults. Implications for Risk Assessment. Guzelian P, Henry CJ, Olin SS, eds. Washington, DC: ILSI Press.
  • Integrated Risk Information System (IRIS). (1991). Formaldehyde. (CASRN 50-00-0). Available at: http://cfpub.epa.gov/ncea/iris/index.cfm?fuseaction=iris.showQuickView&substance_nmbr=0419.
  • Ishmael J, Dugard PH. (2006). A review of perchloroethylene and rat mononuclear cell leukemia. Reg Toxicol Pharmacol 45:178–184.
  • Iwasaki Y, Ishiguro T. (1978). Measurement of odor by triangle odor bag method. Japn Soc Atmos Environ 13:34–39.
  • Johannsen FR, Levinskas GJ, Tegeris AS. (1986). Effects of formaldehyde in the rat and dog following oral exposure. Toxicol Lett 30:1–6.
  • Kamata E, Nakadate M, Uchida O. (1997). Results of a 28-month chronic inhalation toxicity study of formaldehyde in male Fischer-344 rats. J Toxicol Sci 22:239–254.
  • Kane LE, Alarie Y. (1977). Sensory irritation to formaldehyde and acrolein during single and repeated exposures in mice. Am Ind Hyg Assoc J 38:509–522.
  • Kerns WD, Donofrio DJ, Pavkov KL. (1983a). The chronic effects of formaldehyde inhalation in rats and mice: A preliminary report. In: Gibson JE, ed. Formaldehyde Toxicity. Washington, DC: Hemisphere Publishing, 111–131.
  • Kerns WD, Pavkov KL, Donofrio DJ, Gralla EJ, Swenberg JA. (1983b). Carcinogenicity of formaldehyde in rats and mice after long-term inhalation exposure. Cancer Res 43:4382–4392.
  • Kilburn K.H, Warshaw R, Boylen CT. (1985). Pulmonary and neurobehavioral effects of formaldehyde exposure. Arch Environ Health 40:254–260.
  • Kimbell JS, Gross EA, Joyner DR, Godo MN, Morgan KT. (1993). Application of computational fluid dynamics to regional dosimetry of inhaled chemicals in the upper respiratory tract of the rat. Toxicol Appl Pharmacol 121:253–263.
  • Kimbell JS, Gross EA, Richardson RB. (1997). Correlation of regional formaldehyde flux predictions with the distribution of formaldehyde-induced squamous metaplasia in F344 rat nasal passages. Mutat Res 380:143–154.
  • Kimbell JS, Overton JH, Subramaniam RP, Schlosser PM, Morgan KT, Conolly RB, Miller FJ. (2001). Dosimetry modeling of inhaled formaldehyde: Binning nasal flux predictions for quantitative risk assessment. Toxicol Sci 64:111–121.
  • Koppel C, Baudisch H, Schneider V. (1990). Suicidal ingestion of formalin with fatal complications. Intensive Care Med 16:212–214.
  • Krakowiak A, Gorski P, Pazdrak K, Ruta U. et al. (1998). Airway response to formaldehyde inhalation in asthmatic subjects with suspected respiratory formaldehyde sensitization. Am J Ind Med 33:274–281.
  • Krzyzanowski M, Quackenboss JJ, Lebowitz MD. (1990). Chronic respiratory effects of indoor formaldehyde exposure. Environ Res 52:117–125.
  • Kulle TJ. (1993). Acute odor and irritation response in health nonsmokers with formaldehyde exposure. Inhal Toxicol 5:323–332.
  • Kulle TJ, Sauder LR, Hebel JR, Green DJ, Chatham MD. (1987). Formaldehyde dose-response in healthy nonsmokers. J Air Pollut Control Assoc 37:919–924.
  • Kuo HW, Jian GJ, Liu CS. (1997). White blood cell count as an indicator of formaldehyde exposure. Bull Environ Contam Toxicol 59:261–267.
  • Kushch I, Schwarz K, Schwentner L, Baumann B, Dzien A, Schmid A, Unterkofler K, Gastl G, Špan P, Smith D, Amann A. (2008). Compounds enhanced in a mass spectrometric profile of smokers’ exhaled breath versus non-smokers as determined in a pilot study using PTR-MS. J Breath Res 026002 (26 pp). 2(2):026002.
  • Lang I, Bruckner T, Triebig G. (2008). Formaldehyde and chemosensory irritation in humans: A controlled human exposure study. Regul Toxicol Pharmacol 50:23–36.
  • Leonardos G, Kendall D, Barnard N. (1969). Odor threshold determination of 53 odorant chemicals. J Air Pollut Control Assoc 19:91–95.
  • Lu K, Collins LB, Ru H, Bermudez E, Swenberg JA. (2010a). Distribution of DNA adducts caused by inhaled formaldehyde is consistent with induction of nasal carcinoma but not leukemia. Toxicol Sci 116:441–451.
  • Lu K, Moeller B, Doyle-Eisele M, McDonald J, Swenberg J. (2010b). Molecular dosimetry of N2-hydroxymethyl-dG DNA adducts in rats exposed to formaldehyde. Chem Res Toxicol 24(2):159–61.
  • MAK Commission. (2006). Formaldehyde, Official English Translation, Occupational Toxicants: Critical Data Evaluation for MAK Values and Classification of Carcinogens 17:163. xx: German Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area. Berlin. www2.dupont.com/Plastics/en_US/assets/downloads/processing/FETEG_Facts.pdf.
  • Main DM, Hogan TJ. (1983). Health effects of low-level exposure to formaldehyde. J Occup Med 25:896–900.
  • Malaka T, Kodama AM. (1990). Respiratory health of plywood workers occupationally exposed to formaldehyde. Arch Environ Health 45:288–294.
  • Marsh GM, Youk AO. (2004). Reevaluation of mortality risks from leukemia in the formaldehyde cohort study of the National Cancer Institute. Regul Toxicol Pharmacol 40:113–124.
  • Marsh GM, Youk AO. (2005). Reevaluation of mortality risks from nasopharyngeal cancer in the formaldehyde cohort study of the National Cancer Institute. Regul Toxicol Pharmacol 42:275–283.
  • Marsh GM, Youk AO, Buchanich JM, Cassidy LD, Lucas LJ, Esmen NA, Gathuru IM. (2002). Pharyngeal cancer mortality among chemical plant workers exposed to formaldehyde. Toxicol Ind Health 18:257–268.
  • Marsh GM, Youk AO, Buchanich JM, Erdal S, Esmen NA. (2007). Work in the metal industry and nasopharyngeal cancer mortality among formaldehyde-exposed workers. Reg Toxicol Pharmacol 48:308–319.
  • McGregor D, Bolt H, Cogliano V, Richter-Reichhelm HB. (2006). Formaldehyde and glutaraldehyde and nasal cytotoxicity: Case study within the context of the 2006 IPCS Human Framework for the Analysis of a cancer mode of action for humans. Crit Rev Toxicol 36:821–35.
  • McGwin G Jr, Lienert J, Kennedy JI Jr. (2010). Formaldehyde exposure and asthma in children: A systematic review. Environ Health Perspect 118:313–317.
  • Meek ME, Bucher JR, Cohen SM, Dellarco V, Hill RN, Lehman-McKeeman LD, Longfellow DG, Pastoor T, Seed J, Patton DE. (2003). A framework for human relevance analysis of information on carcinogenic modes of action. Crit Rev Toxicol 33:591–653.
  • Meininghaus R, Kouniali A, Mandin C, Cicolella A. (2003). Risk assessment of sensory irritants in indoor air—A case study in a French school. Environ Int 28:553–557.
  • Meng F, Bermudez E, McKinzie PB, Andersen ME, Clewell HJ 3rd, Parsons BL. (2010). Measurement of tumor-associated mutations in the nasal mucosa of rats exposed to varying doses of formaldehyde. Regul Toxicol Pharmacol 57:274–283.
  • Michielsen P, Vandewoude M. (2010). Liver diseases in the older adult. Acta Gastroenterol Belg 73:1–4.
  • Moeller BC, Lu K, Doyle-Eisele M, McDonald J, Gigliotti A, Swenberg J.A. (2011). Determination of N2-hydroxymethyl-dG adducts in nasal epithelium and bone marrow of non-human primates following 13CD2-formaldehyde inhalation exposure. Chem Res Toxicol 24:162–164.
  • Monticello TM, Swenberg JA, Gross EA, Leininger JR, Kimbell JS, Seilkop S, Starr TB, Gibson JE, Morgan KT. (1996). Correlation of regional and nonlinear formaldehyde-induced nasal cancer with proliferating populations of cells. Cancer Res 56:1012–1022.
  • Moser B, Bodrogi F, Eibl G, Lechner M, Rieder J, Lirk P. (2005). Mass spectrometric profile of exhaled breath—Field study by PTR-MS. Respir Physiol Neurobiol 145:295–300.
  • National Academy of Sciences (NAS). (2000). Clearing the Air: Asthma and Indoor Air Exposures. Washington, DC: Institute of Medicine. Available at: http://www.nap.edu/books/0309064961/html
  • National Academy of Sciences (NAS). (2007a). Applications of Toxicogenomic Technologies to Predictive Toxicology and Risk Assessment. Washington, DC: Committee on Applications of Toxicogenomic Technologies to Predictive Toxicology and Risk Assessment, National Research Council.
  • National Academy of Sciences (NAS). (2007b). Emergency and Continuous Exposure Guidance Levels for Selected Submarine Contaminants. Washington, DC: Subcommittee on Emergency and Continuous Exposure Guidance Levels for Selected Submarine Contaminants, Committee on Toxicology, National Research Council.
  • National Academy of Sciences. (2011). Review of the Environmental Protection Agency’s Draft IRIS Assessment of Formaldehyde. National Research Council, National Academy of Sciences, Washington, DC. http://www.nap.edu/catalog.php?record_id=13142.
  • National Industrial Chemicals Notification and Assessment Scheme (NICNAS). (2006). Formaldehyde. Priority Existing Chemical Assessment Report. xx: Australian Department of Health and Ageing. Sydney.
  • National Toxicology Program (NTP). (2009). Formaldehyde Expert Panel Report. Part B. Recommendation for Listing Status for Formaldehyde and Scientific Justification for the Recommendation. Research Triangle Park, NC: NTP.
  • Neuss S, Moepps B, Speit G. (2010). Exposure of human nasal epithelial cells to formaldehyde does not lead to DNA damage in lymphocytes after co-cultivation. Mutagenesis 25:359–364.
  • Nielsen GD, Hougaard KS, Larsen ST, Hammer M, Wolkoff P, Clausen PA, Wilkins CK, Alarie Y. (1999). Acute airway effects of formaldehyde and ozone in BALB/c mice. Hum Exp Toxicol 18:400–409.
  • Nielsen GD, Wolkoff P. (2010). Cancer effects of formaldehyde: A proposal for an indoor air guideline value. Arch Toxicol 84:423–446
  • Noisel N, le Bouchard M, Carrier G. (2007). Evaluation of the health impact of lowering the formaldehyde occupational exposure limit for Quebec workers. Regul Toxicol Pharmacol 48:118–127.
  • Nordman H, Keskinen H, Tuppurainen M. (1985). Formaldehyde asthma—Rare or overlooked? J Allergy Clin Immunol 75:91–99.
  • Office of Environmental Health Hazard Assessment (OEHHA). (2008). Chronic Toxicity Summary: Formaldehyde. Sacramental: California Environmental Protection Agency (Cal/EPA).
  • Organization for Economic Cooperation and Development (OECD). (2002). Formaldehyde; SIDS Initial Assessment Profile at 17-18. Paris: UNEP Publications.
  • Orsière T, Sari-Minodier I, Iarmarcovai G, Botta A. (2006). Genotoxic risk assessment of pathology and anatomy laboratory workers exposed to formaldehyde by use of personal air sampling and analysis of DNA damage in peripheral lymphocytes. Mutat Res 605:30–41.
  • Overton JH, Kimbell JS, Miller FJ. (2001). Dosimetry modeling of inhaled formaldehyde: The human respiratory tract. Toxicol Sci 64:122–134.
  • Paustenbach DY, Alarie Y, Kulle T, Schachter N, Smith R, Swenberg J, Witschi H, Horowitz SB. (1997). A recommended occupational exposure limit for formaldehyde based on irritation. J Toxicol Environ Health 50:217–263.
  • Paustenbach DJ, Gaffney SH. (2006). The role of odor and irritation as well as risk perception in the setting of occupational exposure limits. Int Arch Occup Environ Health 79:339–342.
  • Pazdrak K, Gorski P, Krakowiak A. (1993). Changes in nasal lavage fluid due to formaldehyde inhalation. Int Arch Occup Environ Health 64:515–519.
  • Pinkerton LE, Hein MJ, Stayner LT. (2004). Mortality among a cohort of garment workers exposed to formaldehyde: An update. Occup Environ Med 61:193–200.
  • Pross HF, Day JH, Clark RH. (1987). Immunological studies of subjects with asthma exposed to formaldehyde and urea-formaldehyde foam insulation (UFFI) off products. J Allergy Clin Immunol 79:797–810.
  • Pyatt D, Natelson E, Golden R. (2008). Is inhalation exposure to formaldehyde a biologically plausible cause of lymphohematopoietic malignancies? Reg Toxicol Pharmacol 51:119–133.
  • Reaven GM, Reaven EP. (1980). Effects of age on various aspects of glucose and insulin metabolism. Mol Cell Biochem 31:37–47.
  • Rhomberg LR, Bailey LA, Goodman JE, Hamade A, Mayfield D. (2011). Is exposure to formaldehyde in air causally associated with leukemia?—A hypothesis-based weight-of-evidence analysis. Crit Rev Toxicol In press.
  • Riess U, Tegtbur U, Fauck C, Fuhrmann F, Markewitz D, Salthammer T. (2010). Experimental setup and analytical methods for the non-invasive determination of volatile organic compounds formaldehyde and NOx in exhaled human breath. Anal Chim. Acta 669:53–62.
  • Ritchie IM, Lehnen RG. (1987). Formaldehyde-related health complaints of residents living in mobile and conventional homes. Am J Public Health 77:323–328.
  • Rowley JD. (2000). Molecular genetics in acute leukemia. Leukemia 14:513–517.
  • Rowley JD, Olney HJ. (2002). International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: Overview report. Genes Chrom Cancer 33:331–345.
  • Rumchev KB, Spickett JT, Bulsara MK, Phillips MR, Stick S.M. (2002). Domestic exposure to formaldehyde significantly increases the risk of asthma in young children. Eur Respir J 20:403–408.
  • Rumchev K, Spickett J, Bulsara M, Phillips MR, Stick SM. (2004). Association of domestic exposure to volatile organic compounds with asthma in young children. Thorax 59:746–751.
  • Rusch GM, Clary JJ, Rinehart WE. (1983). A 26-week inhalation toxicity study with formaldehyde in the monkey, rat, and hamster. Toxicol Appl Pharmacol 68:329–343.
  • Sauder LR, Green DJ, Chatham MD. (1987). Acute pulmonary response of asthmatics to 3.0 ppm formaldehyde. Toxicol Ind Health 3:569–577.
  • Schachter EN, Witek TJJ, Brody DJ. (1987). A study of respiratory effects from exposure to 2.0 ppm formaldehyde in occupationally exposed workers. Environ Res 44:188–205.
  • Schachter EN, Witek TJJ, Tosun T. (1986). A study of respiratory effects from exposure to 2 ppm formaldehyde in healthy subjects. Arch Environ Health 41:229–239.
  • Schlosser PM, Lilly PD, Conolly RB, Janszen DB, Kimbell J.S. (2003). Benchmark dose risk assessment for formaldehyde using airflow modeling and a single-compartment DNA-protein cross-link dosimetry model to estimate human equivalent doses. Risk Anal 23:473–487.
  • Schmid O, Speit G. (2007). Genotoxic effects induced by formaldehyde in human blood and implications for the interpretation of biomonitoring studies. Mutagenesis 22:69–74.
  • Scientific Committee for Occupational Exposure Limits (SCOEL). (2008). Formaldehyde. xx: SCOEL/SUM. http://www.google.com/search?hl=en&biw=1065&bih=708&q=SCOEL+FORMALDEHYDE&aq=f&aqi=&aql=&oq
  • Schumacher GE. (1980). Using pharmacokinetics in drug therapy. VII: Pharmacokinetic factors influencing drug therapy in the aged. Am J Hosp Pharm 37:559–562.
  • Sellakumar AR, Snyder CA, Solomon JJ. (1985). Carcinogenicity of formaldehyde and hydrogen chloride in rats. Toxicol Appl Pharmacol 81:401–406.
  • Sheppard D, Eschenbacher WL, Epstein J. (1984). Lack of bronchomotor response to up to 3 ppm formaldehyde in subjects with asthma. Environ Res 35:133–139.
  • Shusterman D, Balmes J, Cone J. (1988). Behavioral sensitization to irritants/odorants after acute overexposures. J Occup Med 30:565–567.
  • Shusterman D, Matovinovic E, Salmon A. (2006). Does Haber’s law apply to human sensory irritation? Inhal Toxicol 18:457–471.
  • SIDS Initial Assessment Report. (2002). Formaldehyde. Paris: Organisation for Economic Co-operation and Development (OECD), United Nations Environment Programme Chemicals Unit (UNEP Chemicals).
  • Soffritti M, Belpiggi F, Lambertini L, Lauriola M, Padovani M, Maltoni C. (2002). Results of long-term experimental studies on the carcinogenicity of formaldehyde and acetaldehyde in rats. Ann N Y Acad Sci 982:87–105.
  • Soffritti M, Maltoni C, Maffei R, Biagi R. (1989). Formaldehyde: An experimental multipotential carcinogen. Toxicol Ind Health 5:699–730.
  • Speit G, Schmid O, Fröhler-Keller M, Lang I, Triebig G. (2007a). Assessment of local genotoxic effects of formaldehyde in humans measured by the micronucleus test with exfoliated buccal mucosa cells. Mutat Res 627:129–135.
  • Speit G, Schmid O, Neuss S, Schütz P. (2008). Genotoxic effects of formaldehyde in the human lung cell line A549 and in primary human nasal epithelial cells. Environ Mol Mutagen 49:300–307.
  • Speit G, Schütz P, Högel J, Schmid O. (2007b). Characterization of the genotoxic potential of formaldehyde in V79 cells. Mutagenesis 22:387–394.
  • Speit G, Zeller J, Schmid O, Elhajouji A, Ma-Hock L, Neuss S. (2009). Inhalation of formaldehyde does not induce systemic genotoxic effects in rats. Mutat Res 677:76–85.
  • Staab CA, Alander J, Morgenstern R, Grafström RC, Höög JO. (2009). The Janus face of alcohol dehydrogenase 3. Chem Biol Interact 178:29–35.
  • Stroup NE, Blair A, Erikson GE. (1986). Brain cancer and other causes of death in anatomists. J Natl Cancer Inst 77:1217–1224.
  • Subramaniam RP, Chen C, Crump KS, DeVoney D, Fox JF, Portier CJ, Schlosser PM, Thompson CM, White P. (2008). Uncertainties in biologically-based modeling of formaldehyde-induced respiratory cancer risk: Identification of key issues. Risk Anal 28:907–923.
  • Swenberg J, Lu K, Moeller B, Gao L, Upton P, Nakamura J, Starr T. (2010). Endogenous versus exogenous DNA adducts: Their role in carcinogenesis, epidemiology and risk assessment. Toxicol Sci 120 Suppl 1:S130–45 In press.
  • Szilagyi E, Mahmud N, Bartholomew A. (2010). The importance of non-human primate models for pre-clinical studies in hematopoiesis. In: Allogeneic Stem Cell Transplantation, Springer Science Press. pp. 767–787.
  • Tang X, Bai Y, Duong A, Smith M.T, Li L, Zhang L. (2009). Formaldehyde in China: Production, consumption, exposure levels, and health effects. Environ Int 35:1210–1224.
  • Thomas J, Haseman JK, Goodman JI, Ward JM, Loughran TP Jr, Spencer PJ. (2007). A review of large granular lymphocytic leukemia in Fischer 344 rats as an initial step toward evaluating the implication of the endpoint to human cancer risk assessment. Toxicol Sci 99:3–19.
  • Thompson CM, Grafstrom RC. (2008). Mechanistic considerations for formaldehyde-induced bronchoconstriction involving S-nitrosoglutathione reductase. J Toxicol Environ Health Part A 71:244–248.
  • Thompson CM, Sonawane B, Grafström RC. (2009). The ontogeny, distribution, and regulation of alcohol dehydrogenase 3: Implications for pulmonary physiology. Drug Metab Dispos 37:1565–1571.
  • Til HP, Woutersen VJ, Feron V. (1989). Two-year drinking-water study of formaldehyde in rats. Food Chem Toxicol 27:77–87.
  • Titenko-Holland N, Levine AJ, Smith MT. (1996). Quantification of epithelial cell micronuclei by fluorescence in situ hybridization (FISH) in mortuary science students exposed to formaldehyde. Mutat Res 37:237–248.
  • Tobe M, Natio K, Kurokawa Y. (1989). Chronic toxicity study on formaldehyde administered orally to rats. Toxicology 56:79–86.
  • US Coast Guard Chemical Hazard Response Information System (CHRIS). (2001). Formaldehyde.
  • US Consumer Product Safety Commission (CPSC). (2010). Comments on Draft EPA/IRIS formaldehyde assessment. Available at: http://cfpub.epa.gov/ncea/iris_drafts/recordisplay.cfm?deid=223603.
  • US Department of Defense (DOD). (2010). Comments on Draft EPA/IRIS formaldehyde assessment. Available at: http://cfpub.epa.gov/ncea/iris_drafts/recordisplay.cfm?deid=223603.
  • US EPA. (2002). Guidelines for Ensuring and Maximizing the Quality, Objectivity, Utility, and Integrity of Information Disseminated by the Environmenatal Protection Agency, US EPA. Office of Environmental Information. 67 Fed Reg 8452, Feb. 22, 2002; Oct. 2002, pp 19–20.
  • US EPA. (2004). Proposed Acute Exposure Guideline Levels (AEGLs) for Formaldehyde (CAS Reg. No. 50-00-0). National Advisory Committee for Acute Exposure Guideline Levels for Hazardous Substances (NAC/AEGL Committee).
  • US EPA National Center for Environmental Assessment (NCEA). (2005). Controlled Exposure to Formaldehyde Via Inhalation: A Categorical Regression Analysis of Human Exposure and Response.
  • US EPA. (2005). Guidelines for Carcinogen Risk Assessment. Washington, DC: Risk Assessment Forum, US EPA.
  • US EPA. (2006a). Health Effects Information Used in Cancer and Noncancer Risk Characterization for the 1999 National-Scale Assessment (NATA). Available at: http://www.epa.gov/ttn/atw/nata1999/99pdfs/healtheffectsinfo.pdf.
  • US EPA. (2006b). National emission standards for hazardous air pollutants: Plywood and composite wood products; List of hazardous air pollutants, lesser quantity designations, source category list; Final rule. 40 CFR 63. Fed Reg 71:8341–8387.
  • US EPA. (2006c). Formaldehyde. Hazard Summary. Available at: www.epa.gov/ttn/atw/hlthef/formalde.htm/l.
  • US EPA. (2010a). Formaldehyde—Inhalation Assessment (CAS No. 50-00-0) In Support of Summary Information on the Integrated Risk Information System (IRIS). Washington, DC: US Environmental Protection Agency. EPA/635/R-10/002A.
  • US EPA. (2010b). Lymphohematopoietic Cancers Induced by Chemicals and Other Agents: Overview and Implications for Risk Assessment. Washington, DC: US Environmental Protection Agency. EPA/600/R-10/095A
  • US Food and Drug Administration (FDA). (1998). Indirect food additives adjuvants production aids and sanitizers. Fed Reg 63:35134–35135.
  • Vargova M, Wagnerova J, Liskova A. (1993). Subacute immunotoxicity study of formaldehyde in male rats. Drug Chem Toxicol 16:255–275.
  • Vestal RF. (1982). Pharmacology and aging. J Am Geriatr Soc 30:191–200.
  • Woutersen RA, Appleman LM, Wilmer JW. (1987). Subchronic (13-week) inhalation toxicity study of formaldehyde in rats. J Appl Toxicol 7:43–49.
  • Walrath J, Fraumeni JFJ. (1983). Proportionate mortality among New York embalmers. In: Gibson JE, ed. Formaldehyde Toxicity. Washington, DC: Hemisphere Publishing, 227–236.
  • Walrath J, Fraumeni JFJ. (1984). Cancer and other causes of death among embalmers. Cancer Res 44:4638–4641.
  • Weber-Tschopp A, Fischer T, Grandjean E. (1977). Irritating effects of formaldehyde on men. Int Arch Occup Environ Health 39:207–218.
  • Weisel CP, Zhang J, Turpin BJ, Morandi MT, Colome S, Stock TH. (2005). Relationships of indoor outdoor and personal air (RIOPA). Part I. Collection methods and descriptive analyses. Res Rep Health Eff Inst (130 Pt 1):1–107.
  • Witek TJJ, Schachter EN, Tosun T, Beck GJ, Leaderer BP, et al. (1987). An evaluation of respiratory effects following exposure to 2.0 ppm formaldehyde in asthmatics: Lung function symptoms and airway reactivity. Arch Environ Health 42:230–237.
  • Wolkoff P, Nielsen GD. (2010). Non-cancer effects of formaldehyde and relevance for setting an indoor air guideline. Environ Int 36:788–799.
  • World Health Organization (WHO). (2010). Formaldehyde. Concise International Chemical Assessment Document 40. Geneva: World Health Organization.
  • World Health Organization (WHO). (2000). WHO guidelines for indoor air quality: selected pollutants. The WHO European Centre for Environment and Health, Bonn Office.
  • Woutersen R. (2010). Indications for leukaemia and lymphoma in former animal studies. In: Formaldehyde International Science Conference, Barcelona, 20–21 September 2007. Available at: www.formacare.org/fileadmin/formaldehyde/PDF/Woutersen_formaldehyde_leukemia.pdf. Accessed 19 May 2010.
  • Zhang L, Steinmaus C, Eastmond DA, Xin XK, and Smith MT. (2009). Formaldehyde exposure and leukemia: A new meta-analysis and potential mechanisms. Mutat Res 681:150–168.
  • Zhang L, Tang X, Rothmanm N, Vermeulen R, Ji Z, Shen M, Qiu C, Guo W, Liu S, Reiss B, Beane Freeman L, Ge Y, Hubbard A.E, Hua M, Blair A, Galvan N, Ruan X, Alter BP, Xin KX, Li S, Moore LE, Kim S, Xie Y, Hayes RB, Azuma M, Hauptmann M, Xiong J, Stewart P, Laiyu L, Rappaport SM, Huang H, Fraumeni JF, Smith MT, Lan Q. (2010). Occupational exposure to formaldehyde, hematotoxicity and leukemia-specific chromosome changes in cultured myeloid progenitor cells. Cancer Epidemol Biomark Prev 19:80–88.
  • Zheng J, Wang X, Hu Y, Yang J, Liu J, He Y, Gong Q, Yao J, Li X, Du W, Huang S. (2008). A correlation study of immunophenotypic, cytogenetic, and clinical features of 180 AML patients in China. Cytom B Clin Cytom 74:25–29.